Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS

Nature Medicine

Volumn 19, Issue 9, 2013, Pages 1161-1165

  Bittner, Stefan ^a   Ruck, Tobias ^a   Schuhmann, Michael K ^a,b   Herrmann, Alexander M ^a   Maati, Hamid Moha Ou ^c   Bobak, Nicole ^a   Göbel, Kerstin ^a   Langhauser, Friederike ^b   Stegner, David ^b,d   Ehling, Petra ^a   Borsotto, Marc ^c   Pape, Hans Christian ^a   Nieswandt, Bernhard ^d   Kleinschnitz, Christoph ^b   Heurteaux, Catherine ^c   Galla, Hans Joachim ^a   Budde, Thomas ^a   Wiendl, Heinz ^a   Meuth, Sven G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; GAMMA INTERFERON; LINSEED OIL; MITOGEN ACTIVATED PROTEIN KINASE; OMEGA 3 FATTY ACID; POTASSIUM CHANNEL; RILUZOLE; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA; TWIK RELATED POTASSIUM CHANNEL 1; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LEUKOCYTE; MOUSE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; UPREGULATION;

ACTINS; ANIMALS; ANTICONVULSANTS; BLOOD-BRAIN BARRIER; BRAIN; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENDOTHELIAL CELLS; FEMALE; HEK293 CELLS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-ALPHA; LEUKOCYTES; LINSEED OIL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RILUZOLE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

MUS;

EID: 84883758881     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3303     Document Type: Article

References (35)

1. Neuwelt, E.A. et al. Engaging neuroscience to advance translational research in brain barrier biology. Nat. Rev. Neurosci. 12, 169-182 (2011).
2. Holman, D.W., Klein, R.S. & Ransohoff, R.M. The blood-Brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 1812, 220-230 (2011).
3. Weiss, N., Miller, F., Cazaubon, S. & Couraud, P.O. The blood-Brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta 1788, 842-857 (2009).
4. Overington, J.P., Al-Lazikani, B. & Hopkins, A.L. How many drug targets are there? Nat. Rev. Drug Discov. 5, 993-996 (2006). (Pubitemid 44835126)
5. Honoré, E. The neuronal background K2P channels: Focus on TREK1. Nat. Rev. Neurosci. 8, 251-261 (2007). (Pubitemid 46452327)
6. Heurteaux, C. et al. Deletion of the background potassium channel TREK-1 results in a depression-Resistant phenotype. Nat. Neurosci. 9, 1134-1141 (2006). (Pubitemid 44306306)
7. Alloui, A. et al. TREK-1, a K+ channel involved in polymodal pain perception. EMBO J. 25, 2368-2376 (2006). (Pubitemid 44012220)
8. Heurteaux, C., Laigle, C., Blondeau, N., Jarretou, G. & Lazdunski, M. &szlic-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 137, 241-251 (2006). (Pubitemid 43031491)
9. Mazella, J. et al. Spadin, a sortilin-Derived peptide, targeting rodent TREK-1 channels: A new concept in the antidepressant drug design. PLoS Biol. 8, e1000355 (2010).
10. Wang, Q. & Doerschuk, C.M. The signaling pathways induced by neutrophil-Endothelial cell adhesion. Antioxid. Redox Signal. 4, 39-47 (2002). (Pubitemid 34260685)
11. Garry, A. et al. Altered acetylcholine, bradykinin and cutaneous pressure-Induced vasodilation in mice lacking the TREK1 potassium channel: The endothelial link. EMBO Rep. 8, 354-359 (2007). (Pubitemid 46519748)
12. Namiranian, K. et al. Cerebrovascular responses in mice deficient in the potassium channel, TREK-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 299, R461-R469 (2010).
13. Duprat, F. et al. The neuroprotective agent riluzole activates the two P domain K+ channels TREK-1 and TRAAK. Mol. Pharmacol. 57, 906-912 (2000). (Pubitemid 30253373)
14. Gilgun-Sherki, Y., Panet, H., Melamed, E. & Offen, D. Riluzole suppresses experimental autoimmune encephalomyelitis: Implications for the treatment of multiple sclerosis. Brain Res. 989, 196-204 (2003). (Pubitemid 37211423)
15. Nordøy, A. Dietary fatty acids and coronary heart disease. Lipids 34 (suppl.), S19-S22 (1999).
16. Lauritzen, I. et al. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 19, 1784-1793 (2000). (Pubitemid 30204390)
17. Nguemeni, C. et al. Dietary supplementation of α-linolenic acid in an enriched rapeseed oil diet protects from stroke. Pharmacol. Res. 61, 226-233 (2010).
18. Lauritzen, I. et al. Cross-Talk between the mechano-gated K2P channel TREK-1 and the actin cytoskeleton. EMBO Rep. 6, 642-648 (2005). (Pubitemid 41122432)
19. Heurteaux, C. et al. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 23, 2684-2695 (2004). (Pubitemid 38988239)
20. Bittner, S. et al. TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system. Brain 132, 2501-2516 (2009).
21. Schneider-Hohendorf, T. et al. Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis. Eur. J. Immunol. 40, 3581-3590 (2010).
22. Göbel, K. et al. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking. J. Autoimmun. 36, 106-114 (2011).
23. Huang, Y.H. et al. Specific central nervous system recruitment of HLA-G+ regulatory T cells in multiple sclerosis. Ann. Neurol. 66, 171-183 (2009).
24. Kleinewietfeld, M. et al. CCR6 expression defines regulatory effector/memory-like cells within the CD25+CD4+ T-Cell subset. Blood 105, 2877-2886 (2005). (Pubitemid 40446282)
25. Schuhmann, M.K. et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J. Immunol. 184, 1536-1542 (2010).
26. Bittner, S. et al. Upregulation of K2P5.1 potassium channels in multiple sclerosis. Ann. Neurol. 68, 58-69 (2010).
27. Dodt, H.U. & Zieglgansberger, W. Visualizing unstained neurons in living brain slices by infrared DIC-Videomicroscopy. Brain Res. 537, 333-336 (1990).
28. Moha ou Maati, H. et al. A human TREK-1/HEK cell line: A highly efficient screening tool for drug development in neurological diseases. PLoS ONE 6, e25602 (2011).
29. Duprat, F. et al. The neuroprotective agent riluzole activates the two P-Domain K+ channels TREK-1 and TRAAK. Mol. Pharmacol. 57, 906-912 (2000). (Pubitemid 30253373)
30. Moha ou Maati, H. et al. Spadin as a new antidepressant: Absence of TREK-1-Related side effects. Neuropharmacology 62, 278-288 (2011).
31. De Bock, M. et al. Low extracellular Ca2+ conditions induce an increase in brain endothelial permeability that involves intercellular Ca2+ waves. Brain Res. 1487, 78-87 (2012).
32. Bettelli, E. et al. Myelin oligodendrocyte glycoprotein-Specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197, 1073-1081 (2003). (Pubitemid 36570063)
33. Krishnamoorthy, G., Holz, A. & Wekerle, H. Experimental models of spontaneous autoimmune disease in the central nervous system. J. Mol. Med. (Berl) 85, 1161-1173 (2007). (Pubitemid 47622217)
34. Williams, J.L. et al. Memory cells specific for myelin oligodendrocyte glycoprotein (MOG) govern the transfer of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 234, 84-92 (2011).
35. Dixon, W. & Massey, F. Introduction to Statistical Analysis (McGraw-Hill Companies, New York, 1969).